LMT-28 is the first synthetic IL-6 inhibitor that functions through direct binding to gp130. LMT-28 shows low toxicity and selectively inhibits IL-6-induced phosphorylation of STAT3, JAK2, and gp130.
Specifications & Purity: LMT-28 is the first synthetic IL-6 inhibitor that functions through direct binding to gp130. LMT-28 shows low toxicity and selectively inhibits IL-6-induced phosphorylation of STAT3, JAK2, and gp130.
Grade: Moligand™
Molecular Formula: C17H29NO4
Molecular Weight: 311.42
PubChem CID: 49846977
Isomeric SMILES: CCCCCC(=C)[C@H]([C@H](C)C(=O)N1[C@H](COC1=O)C(C)C)O
Storage Temperature: Protected from light;Store at -20°C;Argon charged
Shipped in: Ice chest + Ice pads
- UPC:
- 41113403
- HazmatClass:
- Yes
- WeightUOM:
- LB
- MPN:
- L649800-500mg
- Country of Origin:
- China
- CAS:
- 1239600-18-0
- Product Size:
- 500mg
- Harmonized Tariff Code:
- 2931.90.90
akash.verma@cenmed.com
(732) 447-1115





